Mode
Text Size
Log in / Sign up
N/A N=6,030 Randomized Triple-blind Supportive Care

Optimizing Electronic Alerts for Acute Kidney Injury

Acute Kidney Injury

Enrolled (actual)
6,030
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcome: Primary: Composite of Progression of AKI, Inpatient Dialysis, or Inpatient Death — 622; 653 Participants — p=0.67

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
AKI Alert (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Jan 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Composite of Progression of AKI, Inpatient Dialysis, or Inpatient Death
622; 653 0.67
SECONDARY
Mortality
265; 272
SECONDARY
Dialysis
93; 106
SECONDARY
AKI Progression
461; 487
SECONDARY
AKI Duration
2108; 2239; 722; 700; 141; 120
SECONDARY
Readmission Rate
SECONDARY
Index Hospitalization Cost
10300; 10600; 19100; 20100
SECONDARY
Proportion of AKI "Best Practices" Achieved Per Subject During Index Hospitalization
1034; 1174; 339; 397; 444; 519
SECONDARY
Number of Subjects With Chart Documentation of AKI
1871; 2141

Summary

This study will enroll hospitalized adults with acute kidney injury (AKI) and randomize them to usual care versus an electronic alert coupled to a "best practices" order set.

Eligibility Criteria

Inclusion Criteria

  • Adult ≥ 18 years admitted to a participating study hospital
  • Acute Kidney Injury as defined by KDIGO consensus creatinine criteria (0.3mg/dl increase in serum creatinine over 48 hours or 50% relative increase over 7 days).

Exclusion Criteria

  • ESKD diagnosis code
  • Dialysis order prior to AKI onset
  • Initial creatinine >=4.0mg/dl
  • Prior admission in which patient was randomized.
  • Admission to hospice service or comfort measures only order
  • Kidney transplant within 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02753751). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search